Chemo-ICI Combo Promising in Soft Tissue Sarcoma

(MedPage Today) -- A combination of eribulin (Halaven) and pembrolizumab (Keytruda) offered promising results in patients with metastatic soft tissue sarcomas that were sensitive to immune checkpoint inhibition (ICI), a researcher reported.
In...